Building on TRIUMF’s 30-years of experience in nuclear medicine and life sciences, the Institute for Advanced Medical Isotopes (IAMI) will be a major new part of TRIUMF life sciences program for research into next-generation, life-saving medical isotopes and radiopharmaceuticals. The 2500 m2 IAMI facility, to be constructed on the TRIUMF campus, will bring together interdisciplinary TRIUMF … Continued
At its core, a rare isotope production target is a material, such as uranium carbide, that when irradiated undergoes nuclear reactions that produce rare isotopes. TRIUMF’s two target drivers, accelerated protons and electrons, can each be used with a variety of target materials to induce different kinds of nuclear reactions and produce different types and … Continued
TRIUMF’s Radiochemistry Annex (RCA) facility, and its 30-person Applied Technology Group (ATG), support the cyclotron-based production of lifesaving diagnostic and treatment medical isotopes for the treatment of about 35,000 people worldwide every week. The facility is the core of TRIUMF’s industrial partnership with BWX Technologies, Inc. (BWXT) which owns three on-site cyclotrons operated and maintained by … Continued
Housed at the opposite end of the Meson Hall from the 520 MeV cyclotron, the TR-13 is TRIUMF’s cyclotron specialized for the production of medical isotopes for both clinical use and research. During the past twenty years, the TR-13, TRIUMF’s smallest cyclotron, has played a central role in the development of the University of British Columbia‘s world-class positron emission tomography (PET) clinical research program, … Continued
TR-24 cyclotron: TRIUMF technology comes full circle The cornerstone of TRIUMF’s Institute for Advanced Medical Isotopes (IAMI) will be a 500 microamp, TR-24 cyclotron designed for the rapid, reliable and high yielding production of medical isotopes. Manufactured by Richmond B.C.-based Advanced Cyclotron Systems Inc. (ACSI), IAMI’s TR-24 cyclotron is an example of TRIUMF’s technology transfer bearing long-term fruit. In the early 1970s, Richmond, B.C.-based heavy industry leader EBCO was … Continued
TRIUMF’s radiochemistry laboratories combine cutting-edge expertise in the research and production of radioisotopes and radiopharmaceuticals for use in nuclear medicine and the broader life sciences. Radioisotopes are imaging molecules and therapeutic drugs whose active component is a short-lived radioactive isotope, also called a medical isotope or radiopharmaceutical. These are the core of nuclear medicine, the … Continued
At TRIUMF’s unique βNMR (beta-detected Nuclear Magnetic Resonance) facility, scientists are using radioactive isotopes to take inside-out, atomic-level snapshots to guide the way to new materials and medicines. βNMR (the Greek-letter β is pronounced ‘beta’) is a next-generation form of the better-known Nuclear Magnetic Resonance (NMR), one of the most important tools in science for characterizing … Continued